BioStrand
Diepenbeek
About BioStrand
BioStrand offers a revolutionary methodology for identifying similarities and variations in genetic data and detecting structural anchor points that will drive innovation in precision medicine, drug development and agriculture. The BioStrand methodology enables unprecedented accuracy in detecting similarities and variations in DNA, RNA and proteins. By detecting HYFTSTM, structural 3D information is automatically integrated into the analyses, revolutionising pattern and profile detection that are critical in unraveling diseases and biological processes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.9M
- Funding stage: M&A
- Last round: Grant (May 2022)
- Website: biostrand.be
- Phone: [email protected]
Industries & Categories
Bioinformatics, Biotechnology, Genetics, Life Science, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/biostrand-79769 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.